DoD Breast Cancer Era of Hope Scholar Award

The summary for the DoD Breast Cancer Era of Hope Scholar Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD Breast Cancer Era of Hope Scholar Award: The BCRP Era of Hope Scholar Award mechanism was first offered in FY04. Since that time, 126 Era of Hope Scholar Award proposals have been received, and 27 have been recommended for funding. The Era of Hope Scholar Award supports individuals who are early in their careers and have high potential for innovation in breast cancer research. These individuals should be exceptionally talented scientists who have demonstrated that they are the "best and brightest" in their field(s) through extraordinary creativity, vision, and productivity. They also should exhibit strong potential for leadership in the breast cancer research community, and be able to articulate a vision for the eradication of breast cancer. Individuals should challenge current dogma and demonstrate an ability to look beyond tradition and convention. The Era of Hope Scholar Award applications must focus on the Principal Investigator's (PI) record of creative and original accomplishments, potential for leadership in the breast cancer research community, and vision for eradicating breast cancer. These aspects of the application will receive significant consideration in the review process in addition to the proposed research project. Experience in breast cancer research is not required; however, the application should focus on breast cancer research, and the PI must commit at least 50% of his/her full-time professional effort during the award period to breast cancer research.